陶皮特负担与海马体微观结构和艾米洛伊德阳性老年人的情节性记忆有关
Daniel D Callow1, Nisha Rani1, Kylie H Alm1
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hippocampus
|September 29, 2025
概括
通过平均扩散度 (MD) 测量的海马体微观结构变化与粉样蛋白阳性个体的记忆力下降和病理有关. 这些微观结构变化可能表明早期阿尔茨海默氏症 (AD) 神经退行.
科学领域:
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病研究研究
- 认知神经学 认知神经学
背景情况:
- 通过扩散权重成像 (DWI) 评估的海马灰质微观结构,显示出作为阿尔茨海默病 (AD) 中神经退行症早期指标的前景.
- 海马中的微观结构变化可能会先于像体积损失这样的宏观结构变化,为早期AD病原体提供了洞察力.
- 粉样蛋白和蛋白病理是阿尔茨海默病的关键标志,影响认知功能和神经退行.
研究的目的:
- 为了研究海马微观结构 (平均扩散率[MD]),负荷 (布拉克阶段PET) 和情节性记忆性能之间的关系.
- 为了确定粉样蛋白负担是否调节海马MD,tau PET和记忆之间的关联.
- 检查TAU PET负担在海马MD和记忆衰退之间的联系中扮演的调解角色.
主要方法:
- 这项研究包括来自BIOCARD队列的192名非痴呆症参与者 (14名有轻度认知障碍[MCI]).
- 扩散加权成像 (DWI) 评估了海马平均扩散率 (MD),而正子发射断层扫描 (PET) 测量了粉样蛋白和负荷 (Braak 阶段II-IV).
- 多个线性回归分析探索了粉样蛋白状况,海马MD,PET和记忆复合分数之间的相互作用,包括调解分析.
主要成果:
- hippocampal MD 的增加与粉样蛋白阳性个体的记忆力较差和较高的 tau PET 负担有关.
- 粉样蛋白状况和海马体MD之间的显著相互作用表明,这些关联是特有的粉样蛋白阳性组.
- 在布拉克II-IV阶段的Tau PET负担统计学上介绍了海马体MD升高和记忆力较差之间的关系,独立于海马体体积,特别是当包括MCI参与者时.
结论:
- 由MD评估的海马体微观结构对早期症状阶段与AD相关的病理负担和神经退行敏感.
- 这些发现突出了粉样蛋白阳性,海马体微观结构完整性,陶积累和早期AD的认知衰退之间的相互作用.
- 海马的微观结构变化可能成为早期AD检测和进展的关键生物标志物,甚至在海马体积显著减少之前.
相关概念视频
Role of Hippocampus in Memory
1.4K
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
1.4K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


